This trial is active, not recruiting.

Condition prostate cancer
Sponsor Stanford University
Start date April 1999
End date December 2021
Trial size 2000 participants
Trial identifier NCT00186368, 76528, PROS0009


The purpose of this study is to investigate gene expression profiles and biologic features of prostate tissue and how they relate to prostate cancer development and growth.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Time perspective prospective

Primary Outcomes

Correlate genotype with pathologic phenotype and clinical outcome.
time frame: one time

Eligibility Criteria

Male participants at least 18 years old.

Inclusion Criteria: - Patient scheduled to undergo either a biopsy or surgery for a prostate condition. Exclusion Criteria: - Patients without a prostate condition

Additional Information

Official title Microarray Analysis of Gene Expression in Prostate Tissues (Translating Prostate Cancer Gene Expression Sub-types)
Principal investigator James Brooks, MD
Trial information was received from ClinicalTrials.gov and was last updated in January 2017.
Information provided to ClinicalTrials.gov by Stanford University.